According to CoherentMI, The checkpoint inhibitor refractory cancer market is estimated to be valued at USD 42.34 Bn in 2025 and is expected to reach USD 95.37 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.3% from 2025 to 2032. https://www.myvipon.com/post/1603723/Checkpoint-Inhibitor-Refractory-Cancer-Market-Estimated-amazon-coupons